CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109. A total of 60 filers reported holding CEMPRA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $90,000 | -86.8% | 27,842 | -81.2% | 0.00% | -100.0% |
Q2 2017 | $681,000 | +116.9% | 148,085 | +77.1% | 0.00% | – |
Q1 2017 | $314,000 | -22.7% | 83,631 | +398.5% | 0.00% | -100.0% |
Q3 2016 | $406,000 | +41.5% | 16,775 | -3.5% | 0.00% | – |
Q2 2016 | $287,000 | -20.5% | 17,390 | -15.7% | 0.00% | -100.0% |
Q1 2016 | $361,000 | -32.5% | 20,621 | +20.0% | 0.00% | 0.0% |
Q4 2015 | $535,000 | +9.4% | 17,182 | -2.3% | 0.00% | 0.0% |
Q3 2015 | $489,000 | -25.3% | 17,578 | -7.8% | 0.00% | 0.0% |
Q2 2015 | $655,000 | -16.2% | 19,057 | -16.4% | 0.00% | -50.0% |
Q1 2015 | $782,000 | +3.3% | 22,785 | -29.2% | 0.00% | 0.0% |
Q4 2014 | $757,000 | +116.3% | 32,201 | +0.9% | 0.00% | +100.0% |
Q3 2014 | $350,000 | +1.7% | 31,929 | -0.4% | 0.00% | 0.0% |
Q2 2014 | $344,000 | +83.0% | 32,049 | +96.9% | 0.00% | – |
Q1 2014 | $188,000 | -6.9% | 16,277 | 0.0% | 0.00% | – |
Q4 2013 | $202,000 | +11.6% | 16,277 | +3.4% | 0.00% | – |
Q3 2013 | $181,000 | +54.7% | 15,743 | +4.6% | 0.00% | – |
Q2 2013 | $117,000 | – | 15,048 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |